White Paper

A Holistic Strategy To Ensure Container Closure Integrity Of Sterile Injectable Vial Product

Derek Duncan, Ph.D., Director Product Line, Lighthouse Instruments

Syringe vaccine

Recent regulatory guidance has triggered changes in industry best practices in the area of container closure integrity testing (CCIT). The increasing implementation of deterministic analytical methods for CCIT has enabled deeper insight into the performance of primary packaging with respect to container closure integrity (CCI). However, assuring good CCI of sterile injectable product goes beyond CCI testing. A more science-based holistic approach that includes robust design & qualification of the process and the implementation of appropriate process controls is required. This article describes a framework enabling such a holistic approach to CCI that assures both the primary packaging and the process contribute to good CCI of sterile injectable vial product.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: